Home/Mill Creek Life Sciences/William Mirsch

WM

William Mirsch

Chief Executive Officer

Mill Creek Life Sciences

Therapeutic Areas

Oncology Regenerative Medicine

Mill Creek Life Sciences Pipeline

Drug	Indication	Phase
PLTMax® / PLTGold®	Cell Culture Supplement for Various Cell Therapies	Commercial
Dendritic Cell Vaccine	Glioblastoma Multiforme (GBM)	Pre-clinical

Leadership Team at Mill Creek Life Sciences

Dr. Vanesa Alonso-Camino

Director, Research and Development

View full Mill Creek Life Sciences profile